Atlas Trials

TIL Therapy in Metastatic Melanoma and IL2 Dose Assessment

Clinical trial NCT01995344 · TERMINATED

Trial details

NCT number
NCT01995344
Sponsor
The Christie NHS Foundation Trust
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Melanoma
Start date
2014-03-01
Primary completion
2015-07-24
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.